Lower is Better

Dr Tom Frieden, former director of CDC, referred to the Final Report of a Trial of Intensive versus Standard Blood-Pressure Control, published in May in the New England Journal of Medicine.

Conclusions:”Among patients who were at increased cardiovascular risk, targeting a systolic blood pressure of less than 120 mm Hg resulted in lower rates of major adverse cardiovascular events and lower all-cause mortality than targeting a systolic blood pressure of less than 140 mm Hg…”

This month I also updated by comparison of the Healthmote BT-105 and the new CardioBlip by Carrematix to our office sphygmomanometer. We are still in the process of talking with both of these companies about their products as we continue to mainly use the Healthmote system for our own RPM services.

More Healthmote Experience

Healthmote continues to lend itself to a growth of patients using RPM. It is easier to set up than Qardio, and we have found that easily more than twice the number of Medicare patients can use the simple one-button Healthmote device compared to Qardio. Send your CCM and RPM questions to mark(at)vaughanmd.com. Emails may not receive a reply, but answers to the most popular questions will be provided in future episode of the CCM Pays and RPM Podcast.